Levy Adam Scott
SEC CIK 1693134 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | CFO, Sec | 48.5K | $100.0K | $9.16M | 13 | 2023-02-14 | 2026-02-19 |
Most active insiders at MLYS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Catalys Pacific Fund, LP | 10% | — | $43.35M |
| 2 | Congleton Jon | CEO, Dir | — | $14.91M |
| 3 | Rodman David Malcom | Chief Medical Off | — | $14.41M |
| 4 | Shah Rajeev M. | Dir | $8.76M | — |
| 5 | Levy Adam Scott | CFO, Sec | — | $6.16M |
| 6 | Warren Eric | Chief Commercial Off | — | $3.30M |
| 7 | Slingsby Brian Taylor | Dir, 10% | — | $3.01M |
| 8 | Gold Alexander M | Dir | — | $1.58M |
| 9 | Karydas Daphne | Dir | — | $925.6K |
| 10 | DiRocco Derek | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-20 | 2026-02-19 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | A - Grant | $0.00 | +39.9K | 48.5K | +462% | $0 |
| 2026-01-13 | 2026-01-12 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale | $32.14 | -10.8K | 8,638 | -55% | -$345.8K | |
| DM | 2025-11-13 | 2025-11-11 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | M - OptEx | $14.11 | +105.7K | 138.9K | +318% | +$1.49M |
| DM | 2025-11-13 | 2025-11-11 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale+OE | $44.87 | -119.5K | 19.4K | -86% | -$5.36M |
| M | 2025-10-15 | 2025-10-13 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale | $42.01 | -10.8K | 116.9K | -8% | -$452.0K |
| M | 2025-07-30 | 2025-07-28+ | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale | $14.62 | -73.7K | 132.9K | -36% | -$1.08M |
| 2025-07-15 | 2025-07-11 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale | $14.45 | -10.8K | 206.6K | -5% | -$155.5K | |
| 2025-04-15 | 2025-04-11 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale | $12.06 | -10.8K | 215.3K | -5% | -$129.7K | |
| M | 2025-01-15 | 2025-01-13 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale | $9.10 | -10.8K | 226.1K | -5% | -$97.8K |
| 2024-10-15 | 2024-10-11 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale | $13.57 | -10.8K | 236.9K | -4% | -$146.0K | |
| 2024-07-12 | 2024-07-11 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale | $13.14 | -10.8K | 247.6K | -4% | -$141.3K | |
| 2024-06-13 | 2024-06-11 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Sec | S - Sale | $12.94 | -96.8K | 255.5K | -27% | -$1.25M | |
| 2023-02-16 | 2023-02-14 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Chief Bus. Off, Secy | P - Purchase | $16.00 | +6,250 | 350.8K | +2% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations